The table below shows Teladoc Health, Inc.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
$2.53B
$2.57B
$2.60B
$2.41B
$2.03B
$1.09B
Cost of revenue
-
-
-
$743.99M
$650.26M
$390.83M
Gross profit
-
-
-
-
-
-
R&D
$277.92M
$307.27M
$348.52M
$333.63M
$311.88M
$164.94M
SG&A
TDOC annual revenue (10-K history)
Teladoc Health, Inc. reported annual revenue of $2.53B for fiscal year 2025. That is down 1.5% from $2.57B in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $123.16M (FY 2016) to $2.53B. Figures come from the company's audited annual reports as filed with the SEC.
